) the first case reported in Britain of severe pulmonary embolism and infarction produced by treatment with enavid. My patient had never been pregnant, had no previous history of thrombophlebitis, and had no varicose veins in the legs. She had none of the proposed contraindications to oral contraception, but only suffered from endometriosis, which was the indication for which enavid was prescribed by her gynaecologist. A daily dose of 20 mg. caused continued vomiting and bilateral pulmonary embolism, with the typical clinical, radiographic, and electrocardiographic features of this disease.
This dreaded and sometimes fatal complication to treatment with enavid can occur without warning in patients with no previous history of thrombophlebitis. The risk of provoking pulmonary embolism should be considered before enavid is prescribed for therapeutic, or "conovid" for contraceptive, purposes.-I am, etc., Bungay, Suffolk. W. M. JORDAN.
SIR,-I read with interest the letter on this subject by Dr. A. R. Hill (July 7, p. 52).
There is a great deal of anxiety associated with the problem of contraception, and its easy solution is everywhere desirable. Oral contraceptives are the cheapest, the easiest, and most relatively certain means of contraception, and consequently have had a great welcome both by the medical profession and the public.
